Drawing for PROTIA

USPTO serial 78137134

PROTIA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
KOVALSKY, LAURA G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROTIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ted Whitlock

TED WHITLOCK ANDRX CORPORATION4955 ORANGE DRDAVIE, FL 33314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GASTRO INTESTINAL DISEASES AND DISORDERSACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 9, 2008ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 7, 2003ABN1ABANDONMENT - EXPRESS MAILED—
Mar 14, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 14, 2003MAILPAPER RECEIVED—
Dec 31, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2002NPUBNOTICE OF PUBLICATION—
Oct 30, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2002CNEAEXAMINER'S AMENDMENT MAILED—
Oct 24, 2002TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 15, 2002DOCKASSIGNED TO EXAMINER—
Oct 15, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance